Inventor
RHINN HERVE
US22 patents
⚠️ This page may combine multiple inventors who share the name “RHINN HERVE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PREVAIL THERAPEUTICS INC
14 patentsUS10689625B2Jun 23, 2020
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC10 citations91
US11661585B2May 30, 2023
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC5 citations84
US11655460B2May 23, 2023
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC3 citations83
US11060113B2Jul 13, 2021
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC8 citations83
US10837028B2Nov 17, 2020
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC9 citations83
US11993790B2May 28, 2024
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC1 citations72
US11802294B2Oct 31, 2023
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC2 citations72
US12571002B2Mar 10, 2026
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC0 citations61
US12570963B2Mar 10, 2026
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC0 citations61
US12049626B2Jul 30, 2024
Gene therapy for neurodegenerative disorders
PREVAIL THERAPEUTICS INC0 citations61
US11807849B2Nov 7, 2023
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC1 citations61
US11903985B2Feb 20, 2024
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC1 citations59
US12516298B2Jan 6, 2026
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC0 citations55
US11999974B2Jun 4, 2024
Gene therapies for lysosomal disorders
PREVAIL THERAPEUTICS INC1 citations55
ALECTOR LLC
8 patentsUS11136390B2Oct 5, 2021
Anti-CD33 antibodies and methods of use thereof
ALECTOR LLC3 citations71
US11472874B2Oct 18, 2022
Anti-MS4A4A antibodies and methods of use thereof
ALECTOR LLC3 citations70
US11667699B2Jun 6, 2023
Anti-MS4A4A antibodies and methods of use thereof
ALECTOR LLC3 citations63
US12319734B2Jun 3, 2025
Anti-TMEM106B antibodies and methods of use thereof
ALECTOR LLC0 citations61
US11440957B2Sep 13, 2022
Anti-TMEM106B antibodies and methods of use thereof
ALECTOR LLC1 citations61
US12331112B2Jun 17, 2025
Anti-MS4A4A antibodies and methods of use thereof
ALECTOR LLC0 citations59
US12331111B2Jun 17, 2025
Anti-MS4A4A antibodies and methods of use thereof
ALECTOR LLC0 citations59
US12215149B2Feb 4, 2025
Anti-MS4A6A antibodies and methods of use thereof
ALECTOR LLC0 citations50